Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor

@article{Weissman1986ExposureOK,
  title={Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor},
  author={A. Weissman and R. Klausner and K. Rao and J. Harford},
  journal={The Journal of Cell Biology},
  year={1986},
  volume={102},
  pages={951 - 958}
}
  • A. Weissman, R. Klausner, +1 author J. Harford
  • Published 1986
  • Biology, Medicine
  • The Journal of Cell Biology
    • When the human erythroleukemia cell line K562 is treated with OKT9, a monoclonal antibody against the transferrin receptor, effects on receptor dynamics and degradation ensue. The apparent half-life of the receptor is decreased by greater than 50% as a result of OKT9 treatment. The transferrin receptor is also rapidly redistributed in response to OKT9 such that a lower percentage of the cellular receptors are displayed on the cell surface. OKT9 treatment also leads to a decrease in the total… CONTINUE READING
    View PDF
    88 Citations
    Highly Influential Citations
    5
    Background Citations
    28
    Methods Citations
    1
    Results Citations
    4

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    88 Citations
    Citation Type

    Citation Type

    A rapid redistribution of the transferrin receptor to the cell surface of HL-60 cells and K562 cells upon treatment with dimethyl sulfoxide due to slowing of endocytosis.
    • 5
    Killing of K562 cells with conjugates between human transferrin and a ribosome‐inactivating protein (SO‐6)
    • 27
    Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments.
    • 61
    Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.
    • 13
    • PDF
    Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.
    • 18
    • PDF
    The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.
    • 454
    Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
    • 102
    • PDF
    Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
    • 51
    • PDF
    Inhibition of lymphocyte activation with anti-transferrin receptor Mabs: a comparison of three reagents and further studies of their range of effects and mechanism of action.
    • 22
    Receptor-mediated endocytosis of 125I-labelled transferrin by human choriocarcinoma (JAR) cells.
    • 7

    References

    SHOWING 1-10 OF 36 REFERENCES
    Rapid internalization of the transferrin receptor in K562 cells is triggered by ligand binding or treatment with a phorbol ester.
    • 137
    • PDF
    Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells.
    • 99
    • PDF
    Receptor-mediated endocytosis of transferrin in K562 cells.
    • 480
    Biosynthetic regulation of the human transferrin receptor by desferrioxamine in K562 cells.
    • 99
    Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies.
    • 85
    • PDF
    Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment.
    • 367
    • PDF
    Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells
    • 567
    • PDF
    Rapid endocytosis of the transferrin receptor in the absence of bound transferrin
    • C. Watts
    • Biology, Medicine
    • The Journal of cell biology
    • 1985
    • 144
    • PDF
    Antibody to mannose 6‐phosphate specific receptor induces receptor deficiency in human fibroblasts.
    • 78
    Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts
    • 283
    • PDF